首页> 外文OA文献 >Duration of first remission and hematopoietic cell transplantation-specific comorbidity index but not age predict survival of patients with AML transplanted in CR2: a retrospective multicenter study

【2h】

Duration of first remission and hematopoietic cell transplantation-specific comorbidity index but not age predict survival of patients with AML transplanted in CR2: a retrospective multicenter study

机译：第一次缓解和造血细胞移植特异性合并症的持续时间，但不是年龄预测在CR2中移植的AML患者的存活：回顾性多中心研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
F V Michelis; E G Atenafu; S Couban; J Frazer; S Shivakumar; D E Hogge; C L Toze; W Rajkhan; H J Kim; A Daly; J Slaby; J Finke; T Kiss; C Bredeson; M Sabloff; D Sheppard; M Bakkar; M Brune; D A Wall; K Paulson; G Popradi; I Walker; H A Messner;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Duration of first remission and hematopoietic cell transplantation-specific comorbidity index but not age predict survival of patients with AML transplanted in CR2: a retrospective multicenter study [J] . Michelis F. V., Atenafu E. G., Couban S., Bone marrow transplantation . 2016,第7期

机译：一项回顾性多中心研究：首次缓解的持续时间和造血细胞移植特异性合并症指数，而非年龄可预测CR2中移植的AML患者的生存
2. Duration of first remission, hematopoietic cell transplantation-specific comorbidity index and patient age predict survival of patients with AML transplanted in second CR [J] . MichelisF.V., AtenafuE.G., GuptaV., Bone marrow transplantation . 2013,第11期

机译：首次缓解的持续时间，造血细胞移植特异性合并症指数和患者年龄可预测第二次CR移植后AML患者的存活率
3. Role of Age and Hematopoietic Cell Transplantation-Specific Comorbidity Index in Myelodysplastic Patients Undergoing an Allotransplant: A Retrospective Study from the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation [J] . Carre Martin, Porcher Raphael, Finke Juergen, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2020,第3期

机译：年龄和造血细胞移植特异性合并症的作用术治疗骨髓塑化患者的作用：欧洲血对血管移植组慢性恶性失误党的回顾性研究
4. Circulating Tumor DNA Predicts Post-Allogeneic Hematopoietic Stem Cell Transplantation in AML and MDS [C] . Sousuke Nakamura International Molecular Medicine Tri-Conference. . 2019

机译：循环肿瘤DNA预测AML和MDS中的同种异体造血干细胞移植
5. Retrospective analysis of survival and treatment related mortality following a myeloablative hematopoietic stem cell transplant in childhood acute lymphoblastic leukemia. [D] . Dasgupta, Sreejeta. 2010

机译：儿童急性淋巴细胞白血病清髓性造血干细胞移植后生存和治疗相关死亡率的回顾性分析。
6. Transplantation: Hematopoietic cell transplantation–specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences [O] . Mohamed L. Sorror, Sergio Giralt, Brenda M. Sandmaier, -1

机译：移植：造血细胞移植特异性合并症指数可作为首次缓解时急性髓性白血病患者的预后指标：FHCRC和MDACC的综合经验
7. Duration of first remission, hematopoietic cell transplantation-specific comorbidity index and patient age predict survival of patients with AML transplanted in second CR [O] . F V Michelis, E G Atenafu, V Gupta, 2013

机译：第一次缓解的持续时间，造血细胞移植特异性合并症指数和患者年龄预测第二次CR中移植的AML患者的存活率

Duration of first remission and hematopoietic cell transplantation-specific comorbidity index but not age predict survival of patients with AML transplanted in CR2: a retrospective multicenter study

著录项

相似文献

相关主题

期刊订阅